Visión generalGráficoNoticiasTraderScreen

Raiffeisen Bank International AG .../  AT0000A37BV1  /

Raiffeisen EE
28/02/2025  0:00:00 Diferencia0.000 Bid- Ask- Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.011EUR 0.00% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 FACC AG INH.AKT. 5.00 EUR 21/03/2025 Put
GlobeNewswire 27/02 Ideal Protein Launches Whitepaper Unveiling Synergistic Approach to Enhance GLP-1 Medication Outcome...
GlobeNewswire 25/02 Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corpo...
GlobeNewswire 24/02 Inhibikase Announces Expansion of Senior Leadership Team
GlobeNewswire 21/02 Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisor...
GlobeNewswire 18/02 Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagli...
GlobeNewswire 14/02 Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial...
GlobeNewswire 31/01 New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
GlobeNewswire 26/08/2024 Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
GlobeNewswire 14/08/2024 19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire 13/08/2024 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of ...
GlobeNewswire 12/08/2024 Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 08/08/2024 Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and ...
GlobeNewswire 31/07/2024 BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
GlobeNewswire 28/07/2024 Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alz...
GlobeNewswire 18/07/2024 HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in ...
GlobeNewswire 17/07/2024 Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mil...
GlobeNewswire 10/07/2024 Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Desig...
GlobeNewswire 09/07/2024 New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
GlobeNewswire 08/07/2024 Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire 17/06/2024 Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...
GlobeNewswire 12/06/2024 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...
GlobeNewswire 10/06/2024 Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
GlobeNewswire 05/06/2024 Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
GlobeNewswire 04/06/2024 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire 17/05/2024 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine